Cargando…
Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
Parkinson’s disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliabi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126820/ https://www.ncbi.nlm.nih.gov/pubmed/30188909 http://dx.doi.org/10.1371/journal.pone.0202597 |
_version_ | 1783353374556553216 |
---|---|
author | Perlbarg, Vincent Lambert, Justine Butler, Benjamin Felfli, Mehdi Valabrègue, Romain Privat, Anne-Laure Lehéricy, Stéphane Petiet, Alexandra |
author_facet | Perlbarg, Vincent Lambert, Justine Butler, Benjamin Felfli, Mehdi Valabrègue, Romain Privat, Anne-Laure Lehéricy, Stéphane Petiet, Alexandra |
author_sort | Perlbarg, Vincent |
collection | PubMed |
description | Parkinson’s disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliability of diffusion MRI and resting-state functional MRI biomarkers in monitoring neurodegeneration in the 6-OHDA rat model assessed by quantitative histology. We performed a unilateral injection of 6-OHDA in the striatum of Sprague Dawley rats to produce retrograde degeneration of the dopamine neurons in the substantia nigra pars compacta. We carried out a longitudinal study with a multi-modal approach combining structural and functional MRI together with quantitative histological validation to follow the effects of the lesion. Functional and structural connectivity were assessed in the brain of 6-OHDA rats and sham rats (NaCl injection) at 3 and 6 weeks post-lesioning using resting-state functional MRI and diffusion-weighted. Our results showed (i) increased functional connectivity in ipsi- and contra-lesioned regions of the cortico-basal ganglia network pathway including the motor cortex, the globus pallidus, and the striatum regions at 3 weeks; (ii) increased fractional anisotropy (FA) in the ipsi- and contralateral striatum of the 6-OHDA group at 3 weeks, and increased axial diffusivity (AD) and mean diffusivity in the ipsilateral striatum at 6 weeks; (iii) a trend for increased FA in both substantia nigra of the 6-OHDA group at 3 weeks. Optical density measurements of tyrosine-hydroxylase (TH) staining of the striatum showed good correlations with the FA and AD measurements in the striatum. No correlations were found between the number of TH-stained dopaminergic neurons and MRI measurements in the substantia nigra. This study suggested that (i) FA and AD were reliable biomarkers to evaluate neurodegeneration in the cortico-basal ganglia network of the 6-OHDA model, (ii) diffusion MRI and resting-state functional MRI (rsfMRI) were not sensitive enough to detect changes in the substantia nigra in this model. |
format | Online Article Text |
id | pubmed-6126820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-61268202018-09-15 Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI Perlbarg, Vincent Lambert, Justine Butler, Benjamin Felfli, Mehdi Valabrègue, Romain Privat, Anne-Laure Lehéricy, Stéphane Petiet, Alexandra PLoS One Research Article Parkinson’s disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliability of diffusion MRI and resting-state functional MRI biomarkers in monitoring neurodegeneration in the 6-OHDA rat model assessed by quantitative histology. We performed a unilateral injection of 6-OHDA in the striatum of Sprague Dawley rats to produce retrograde degeneration of the dopamine neurons in the substantia nigra pars compacta. We carried out a longitudinal study with a multi-modal approach combining structural and functional MRI together with quantitative histological validation to follow the effects of the lesion. Functional and structural connectivity were assessed in the brain of 6-OHDA rats and sham rats (NaCl injection) at 3 and 6 weeks post-lesioning using resting-state functional MRI and diffusion-weighted. Our results showed (i) increased functional connectivity in ipsi- and contra-lesioned regions of the cortico-basal ganglia network pathway including the motor cortex, the globus pallidus, and the striatum regions at 3 weeks; (ii) increased fractional anisotropy (FA) in the ipsi- and contralateral striatum of the 6-OHDA group at 3 weeks, and increased axial diffusivity (AD) and mean diffusivity in the ipsilateral striatum at 6 weeks; (iii) a trend for increased FA in both substantia nigra of the 6-OHDA group at 3 weeks. Optical density measurements of tyrosine-hydroxylase (TH) staining of the striatum showed good correlations with the FA and AD measurements in the striatum. No correlations were found between the number of TH-stained dopaminergic neurons and MRI measurements in the substantia nigra. This study suggested that (i) FA and AD were reliable biomarkers to evaluate neurodegeneration in the cortico-basal ganglia network of the 6-OHDA model, (ii) diffusion MRI and resting-state functional MRI (rsfMRI) were not sensitive enough to detect changes in the substantia nigra in this model. Public Library of Science 2018-09-06 /pmc/articles/PMC6126820/ /pubmed/30188909 http://dx.doi.org/10.1371/journal.pone.0202597 Text en © 2018 Perlbarg et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Perlbarg, Vincent Lambert, Justine Butler, Benjamin Felfli, Mehdi Valabrègue, Romain Privat, Anne-Laure Lehéricy, Stéphane Petiet, Alexandra Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI |
title | Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI |
title_full | Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI |
title_fullStr | Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI |
title_full_unstemmed | Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI |
title_short | Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI |
title_sort | alterations of the nigrostriatal pathway in a 6-ohda rat model of parkinson’s disease evaluated with multimodal mri |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126820/ https://www.ncbi.nlm.nih.gov/pubmed/30188909 http://dx.doi.org/10.1371/journal.pone.0202597 |
work_keys_str_mv | AT perlbargvincent alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri AT lambertjustine alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri AT butlerbenjamin alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri AT felflimehdi alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri AT valabregueromain alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri AT privatannelaure alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri AT lehericystephane alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri AT petietalexandra alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri |